| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Th2 Cells | 28 | 2022 | 152 | 4.170 |
Why?
|
| Asthma | 28 | 2026 | 1078 | 3.540 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 12 | 2011 | 98 | 2.520 |
Why?
|
| Lung | 33 | 2026 | 1406 | 2.220 |
Why?
|
| Dendritic Cells | 12 | 2023 | 552 | 2.190 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 8 | 2026 | 238 | 1.900 |
Why?
|
| T-Lymphocytes | 30 | 2021 | 1331 | 1.870 |
Why?
|
| Interleukin-33 | 7 | 2026 | 33 | 1.540 |
Why?
|
| Lymph Nodes | 12 | 2025 | 560 | 1.430 |
Why?
|
| Hypersensitivity | 8 | 2019 | 166 | 1.350 |
Why?
|
| Cytokines | 21 | 2023 | 889 | 1.280 |
Why?
|
| Adaptive Immunity | 4 | 2025 | 193 | 1.260 |
Why?
|
| Inducible T-Cell Co-Stimulator Protein | 12 | 2017 | 19 | 1.250 |
Why?
|
| Lung Diseases, Interstitial | 6 | 2025 | 322 | 1.250 |
Why?
|
| Inflammation | 16 | 2025 | 1121 | 1.240 |
Why?
|
| Mice | 77 | 2026 | 12698 | 1.230 |
Why?
|
| Receptors, IgG | 4 | 2018 | 70 | 1.180 |
Why?
|
| T-Lymphocyte Subsets | 16 | 2020 | 291 | 1.150 |
Why?
|
| Mice, Inbred C57BL | 44 | 2025 | 3604 | 1.120 |
Why?
|
| Animals | 95 | 2026 | 28899 | 1.120 |
Why?
|
| Disease Models, Animal | 28 | 2025 | 2571 | 1.090 |
Why?
|
| Interferon Regulatory Factors | 2 | 2022 | 76 | 1.080 |
Why?
|
| Immunity, Innate | 7 | 2021 | 481 | 1.040 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 17 | 2026 | 119 | 1.010 |
Why?
|
| Allergens | 7 | 2025 | 196 | 1.010 |
Why?
|
| Lymphocyte Activation | 22 | 2026 | 822 | 0.990 |
Why?
|
| fas Receptor | 4 | 2018 | 73 | 0.970 |
Why?
|
| CD4-Positive T-Lymphocytes | 8 | 2013 | 505 | 0.960 |
Why?
|
| CD28 Antigens | 12 | 2018 | 94 | 0.930 |
Why?
|
| Lymphocytes | 4 | 2021 | 461 | 0.920 |
Why?
|
| Antigens, CD | 15 | 2015 | 484 | 0.910 |
Why?
|
| Leukosialin | 10 | 2013 | 16 | 0.880 |
Why?
|
| Signal Transduction | 22 | 2024 | 3623 | 0.880 |
Why?
|
| Mice, Knockout | 25 | 2021 | 2206 | 0.860 |
Why?
|
| Lung Diseases | 5 | 2025 | 284 | 0.850 |
Why?
|
| Eosinophils | 6 | 2021 | 196 | 0.840 |
Why?
|
| Acute Lung Injury | 3 | 2022 | 73 | 0.820 |
Why?
|
| Immunologic Memory | 5 | 2022 | 188 | 0.780 |
Why?
|
| Th1 Cells | 9 | 2018 | 173 | 0.760 |
Why?
|
| Hypersensitivity, Immediate | 4 | 2019 | 64 | 0.760 |
Why?
|
| Alveolitis, Extrinsic Allergic | 4 | 2026 | 45 | 0.740 |
Why?
|
| Pulmonary Fibrosis | 6 | 2024 | 158 | 0.720 |
Why?
|
| Sialoglycoproteins | 6 | 2004 | 31 | 0.700 |
Why?
|
| Cell Differentiation | 11 | 2021 | 1646 | 0.690 |
Why?
|
| Eosinophilia | 4 | 2018 | 87 | 0.660 |
Why?
|
| Antigen-Presenting Cells | 9 | 2009 | 146 | 0.650 |
Why?
|
| Gene Expression Regulation | 10 | 2022 | 2019 | 0.640 |
Why?
|
| Interleukin-5 | 4 | 2021 | 36 | 0.610 |
Why?
|
| Bronchoalveolar Lavage Fluid | 11 | 2024 | 136 | 0.600 |
Why?
|
| Mice, Transgenic | 17 | 2026 | 1605 | 0.590 |
Why?
|
| Interleukins | 4 | 2015 | 135 | 0.590 |
Why?
|
| Immunoglobulin E | 10 | 2025 | 156 | 0.590 |
Why?
|
| Bleomycin | 5 | 2024 | 102 | 0.580 |
Why?
|
| Respiratory Hypersensitivity | 4 | 2020 | 36 | 0.570 |
Why?
|
| Environmental Exposure | 3 | 2025 | 405 | 0.570 |
Why?
|
| Lymphopenia | 1 | 2018 | 31 | 0.570 |
Why?
|
| Cells, Cultured | 16 | 2019 | 2854 | 0.560 |
Why?
|
| Cytoskeletal Proteins | 4 | 2013 | 225 | 0.560 |
Why?
|
| Flow Cytometry | 10 | 2019 | 720 | 0.560 |
Why?
|
| Adoptive Transfer | 9 | 2018 | 174 | 0.560 |
Why?
|
| B7-1 Antigen | 7 | 2008 | 75 | 0.550 |
Why?
|
| Humans | 84 | 2026 | 97883 | 0.520 |
Why?
|
| Pneumonia | 4 | 2018 | 195 | 0.520 |
Why?
|
| Cell Movement | 9 | 2013 | 815 | 0.510 |
Why?
|
| Agriculture | 1 | 2016 | 46 | 0.480 |
Why?
|
| Respiratory System | 3 | 2019 | 120 | 0.470 |
Why?
|
| Schistosoma mansoni | 6 | 2011 | 17 | 0.460 |
Why?
|
| Transcription, Genetic | 5 | 2019 | 1133 | 0.460 |
Why?
|
| Cell Communication | 4 | 2006 | 223 | 0.460 |
Why?
|
| Mice, Inbred BALB C | 15 | 2016 | 1110 | 0.450 |
Why?
|
| Chemotaxis, Leukocyte | 2 | 2015 | 39 | 0.440 |
Why?
|
| Monocytes | 2 | 2024 | 219 | 0.440 |
Why?
|
| Receptors, CCR7 | 2 | 2013 | 20 | 0.440 |
Why?
|
| Immunoconjugates | 5 | 2001 | 138 | 0.440 |
Why?
|
| Leukocytes, Mononuclear | 6 | 2024 | 213 | 0.420 |
Why?
|
| Lectins, C-Type | 1 | 2014 | 74 | 0.410 |
Why?
|
| Female | 41 | 2026 | 51464 | 0.410 |
Why?
|
| B-Lymphocytes | 7 | 2021 | 727 | 0.400 |
Why?
|
| Immune Tolerance | 5 | 2015 | 386 | 0.390 |
Why?
|
| Antigens, Differentiation | 6 | 2001 | 125 | 0.380 |
Why?
|
| Staphylococcus aureus | 4 | 2021 | 290 | 0.380 |
Why?
|
| Thymus Gland | 6 | 2026 | 205 | 0.370 |
Why?
|
| Staphylococcal Infections | 4 | 2020 | 285 | 0.370 |
Why?
|
| Th17 Cells | 4 | 2024 | 97 | 0.370 |
Why?
|
| Farms | 2 | 2025 | 11 | 0.350 |
Why?
|
| Microfilament Proteins | 3 | 2013 | 211 | 0.340 |
Why?
|
| L-Selectin | 1 | 2011 | 17 | 0.340 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2025 | 298 | 0.340 |
Why?
|
| T-Lymphocytes, Regulatory | 6 | 2025 | 358 | 0.330 |
Why?
|
| Epithelial Cells | 5 | 2019 | 709 | 0.320 |
Why?
|
| Microbiota | 3 | 2025 | 467 | 0.320 |
Why?
|
| Membrane Proteins | 6 | 2013 | 1285 | 0.320 |
Why?
|
| Fas Ligand Protein | 2 | 2009 | 47 | 0.310 |
Why?
|
| Phenotype | 13 | 2022 | 2638 | 0.300 |
Why?
|
| Male | 33 | 2026 | 46992 | 0.300 |
Why?
|
| Leukocytes | 3 | 2023 | 212 | 0.280 |
Why?
|
| Respiratory Mucosa | 3 | 2021 | 91 | 0.280 |
Why?
|
| Myofibroblasts | 2 | 2023 | 51 | 0.270 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2021 | 118 | 0.270 |
Why?
|
| Apoptosis | 6 | 2019 | 1752 | 0.260 |
Why?
|
| Bacillus subtilis | 2 | 2024 | 95 | 0.250 |
Why?
|
| Proteins | 2 | 2011 | 803 | 0.250 |
Why?
|
| Bronchial Hyperreactivity | 4 | 2014 | 73 | 0.250 |
Why?
|
| Autoantibodies | 2 | 2025 | 286 | 0.250 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2023 | 700 | 0.250 |
Why?
|
| Matrix Metalloproteinase 12 | 1 | 2026 | 2 | 0.240 |
Why?
|
| Gene Expression | 10 | 2023 | 1320 | 0.240 |
Why?
|
| Endothelium | 1 | 2026 | 63 | 0.240 |
Why?
|
| Sinusitis | 2 | 2005 | 216 | 0.230 |
Why?
|
| Autoimmune Diseases | 2 | 2006 | 259 | 0.230 |
Why?
|
| GATA3 Transcription Factor | 3 | 2021 | 53 | 0.230 |
Why?
|
| Bronchi | 3 | 2015 | 229 | 0.230 |
Why?
|
| Pneumococcal Infections | 1 | 2005 | 44 | 0.220 |
Why?
|
| Peroxisomes | 1 | 2025 | 8 | 0.220 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2013 | 373 | 0.220 |
Why?
|
| Neutrophils | 4 | 2021 | 345 | 0.220 |
Why?
|
| HLA-G Antigens | 2 | 2017 | 52 | 0.220 |
Why?
|
| Acetates | 1 | 2025 | 60 | 0.220 |
Why?
|
| Vitiligo | 1 | 2024 | 20 | 0.220 |
Why?
|
| Shock, Septic | 2 | 2023 | 135 | 0.220 |
Why?
|
| Immunity, Cellular | 4 | 2013 | 187 | 0.220 |
Why?
|
| Pulmonary Alveoli | 1 | 2025 | 71 | 0.220 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2025 | 2558 | 0.220 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2024 | 34 | 0.210 |
Why?
|
| Skin Pigmentation | 1 | 2024 | 37 | 0.210 |
Why?
|
| Sepsis | 2 | 2020 | 401 | 0.210 |
Why?
|
| Promoter Regions, Genetic | 2 | 2021 | 975 | 0.210 |
Why?
|
| Lymphocyte Subsets | 2 | 2015 | 71 | 0.210 |
Why?
|
| Macrophages, Alveolar | 1 | 2025 | 67 | 0.210 |
Why?
|
| Menopause | 1 | 2025 | 94 | 0.210 |
Why?
|
| Antibodies | 2 | 2018 | 348 | 0.210 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2025 | 2555 | 0.210 |
Why?
|
| Autoimmunity | 2 | 2024 | 195 | 0.210 |
Why?
|
| Receptors, Antigen, T-Cell | 6 | 2013 | 452 | 0.210 |
Why?
|
| Bacteremia | 3 | 2020 | 110 | 0.200 |
Why?
|
| Influenza, Human | 2 | 2021 | 357 | 0.200 |
Why?
|
| Laminin | 1 | 2024 | 89 | 0.200 |
Why?
|
| Glutamine | 1 | 2024 | 98 | 0.200 |
Why?
|
| Receptors, Androgen | 1 | 2024 | 125 | 0.200 |
Why?
|
| Interleukin-2 | 9 | 2018 | 246 | 0.200 |
Why?
|
| Regeneration | 1 | 2025 | 162 | 0.200 |
Why?
|
| HLA-A2 Antigen | 1 | 2023 | 32 | 0.200 |
Why?
|
| Pulmonary Edema | 2 | 2021 | 54 | 0.200 |
Why?
|
| Inducible T-Cell Co-Stimulator Ligand | 3 | 2011 | 3 | 0.200 |
Why?
|
| Middle Aged | 16 | 2026 | 29353 | 0.190 |
Why?
|
| Up-Regulation | 5 | 2020 | 743 | 0.190 |
Why?
|
| Extracellular Traps | 1 | 2022 | 17 | 0.190 |
Why?
|
| Amish | 2 | 2019 | 6 | 0.180 |
Why?
|
| Aged | 12 | 2026 | 21702 | 0.180 |
Why?
|
| Probiotics | 1 | 2023 | 99 | 0.180 |
Why?
|
| Mediastinum | 2 | 2019 | 42 | 0.180 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 219 | 0.180 |
Why?
|
| Interleukin-13 | 3 | 2019 | 42 | 0.180 |
Why?
|
| CD3 Complex | 4 | 2018 | 137 | 0.180 |
Why?
|
| Bone Marrow Cells | 2 | 2013 | 269 | 0.170 |
Why?
|
| Cell Membrane | 2 | 2009 | 673 | 0.170 |
Why?
|
| Chromosome Mapping | 4 | 2025 | 1061 | 0.170 |
Why?
|
| Immunity | 2 | 2020 | 160 | 0.170 |
Why?
|
| Interleukin-10 | 3 | 2013 | 167 | 0.170 |
Why?
|
| Epigenesis, Genetic | 2 | 2016 | 585 | 0.170 |
Why?
|
| Isoenzymes | 2 | 2013 | 272 | 0.170 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 2021 | 5 | 0.170 |
Why?
|
| Respiratory Tract Infections | 1 | 2022 | 111 | 0.170 |
Why?
|
| Interleukin-4 | 3 | 2011 | 136 | 0.170 |
Why?
|
| DNA Methylation | 2 | 2016 | 730 | 0.170 |
Why?
|
| Protein Kinase C | 2 | 2013 | 267 | 0.170 |
Why?
|
| Biomarkers | 7 | 2026 | 2016 | 0.170 |
Why?
|
| Disease Susceptibility | 2 | 2020 | 225 | 0.170 |
Why?
|
| Graft vs Host Disease | 1 | 2023 | 379 | 0.170 |
Why?
|
| Palatine Tonsil | 1 | 2021 | 34 | 0.170 |
Why?
|
| Thioredoxins | 1 | 2020 | 12 | 0.160 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2020 | 17 | 0.160 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2024 | 310 | 0.160 |
Why?
|
| Colitis | 1 | 2023 | 264 | 0.160 |
Why?
|
| Academic Medical Centers | 1 | 2023 | 407 | 0.160 |
Why?
|
| Leukocyte Count | 2 | 2021 | 214 | 0.160 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2020 | 26 | 0.160 |
Why?
|
| Body Temperature | 1 | 2020 | 127 | 0.160 |
Why?
|
| Adjuvants, Immunologic | 4 | 2021 | 176 | 0.160 |
Why?
|
| Nanofibers | 1 | 2020 | 33 | 0.160 |
Why?
|
| Lymphangiogenesis | 1 | 2020 | 44 | 0.160 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2020 | 94 | 0.160 |
Why?
|
| Thrombosis | 1 | 2022 | 318 | 0.150 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2019 | 10 | 0.150 |
Why?
|
| Lung Transplantation | 3 | 2020 | 390 | 0.150 |
Why?
|
| Immunophenotyping | 6 | 2020 | 227 | 0.150 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2019 | 18 | 0.150 |
Why?
|
| Pyridones | 1 | 2020 | 75 | 0.150 |
Why?
|
| Influenza Vaccines | 1 | 2021 | 176 | 0.150 |
Why?
|
| Cell Adhesion Molecules | 1 | 2000 | 184 | 0.150 |
Why?
|
| Child | 6 | 2025 | 7680 | 0.140 |
Why?
|
| Lung Injury | 2 | 2024 | 61 | 0.140 |
Why?
|
| Adult | 16 | 2025 | 29453 | 0.140 |
Why?
|
| Fungi | 1 | 2019 | 70 | 0.140 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2015 | 302 | 0.140 |
Why?
|
| Genomics | 1 | 2025 | 898 | 0.140 |
Why?
|
| Genome-Wide Association Study | 4 | 2025 | 1850 | 0.140 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 4 | 1997 | 117 | 0.140 |
Why?
|
| Immunosuppressive Agents | 3 | 2001 | 1013 | 0.140 |
Why?
|
| Transcriptome | 3 | 2019 | 820 | 0.140 |
Why?
|
| Indoles | 1 | 2020 | 334 | 0.140 |
Why?
|
| Lymphoid Tissue | 2 | 2021 | 54 | 0.140 |
Why?
|
| Antigens, Helminth | 3 | 2011 | 20 | 0.140 |
Why?
|
| Macrophages | 3 | 2024 | 643 | 0.130 |
Why?
|
| Antigen Presentation | 5 | 2007 | 234 | 0.130 |
Why?
|
| Lymphocyte Count | 3 | 2018 | 99 | 0.130 |
Why?
|
| Interleukin-6 | 1 | 2019 | 282 | 0.130 |
Why?
|
| Population | 1 | 2017 | 36 | 0.130 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 271 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2001 | 682 | 0.130 |
Why?
|
| Stem Cells | 1 | 2019 | 396 | 0.120 |
Why?
|
| Christianity | 1 | 2016 | 36 | 0.120 |
Why?
|
| Disease Progression | 5 | 2020 | 1609 | 0.120 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2016 | 53 | 0.120 |
Why?
|
| Dust | 1 | 2016 | 26 | 0.120 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2016 | 59 | 0.120 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 1778 | 0.120 |
Why?
|
| Abatacept | 5 | 2001 | 89 | 0.120 |
Why?
|
| Physicians | 1 | 2023 | 685 | 0.120 |
Why?
|
| Ovalbumin | 4 | 2015 | 105 | 0.120 |
Why?
|
| RGS Proteins | 2 | 2013 | 22 | 0.120 |
Why?
|
| CTLA-4 Antigen | 5 | 2001 | 146 | 0.110 |
Why?
|
| Time Factors | 6 | 2015 | 5555 | 0.110 |
Why?
|
| Calcitriol | 1 | 2016 | 173 | 0.110 |
Why?
|
| Prevalence | 2 | 2017 | 1384 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 5 | 2002 | 1416 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 1996 | 212 | 0.110 |
Why?
|
| Bacterial Translocation | 1 | 2015 | 26 | 0.110 |
Why?
|
| Salmonella Infections, Animal | 1 | 2015 | 11 | 0.110 |
Why?
|
| Models, Animal | 1 | 2016 | 279 | 0.110 |
Why?
|
| Toxoplasmosis, Animal | 1 | 2015 | 19 | 0.110 |
Why?
|
| Immunotherapy | 1 | 2001 | 821 | 0.110 |
Why?
|
| Salmonella typhimurium | 1 | 2015 | 33 | 0.110 |
Why?
|
| Protein Kinase C-theta | 2 | 2013 | 16 | 0.110 |
Why?
|
| Pandemics | 1 | 2021 | 913 | 0.110 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2023 | 95 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2011 | 557 | 0.110 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2014 | 11 | 0.110 |
Why?
|
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2014 | 12 | 0.110 |
Why?
|
| Polymorphism, Genetic | 1 | 2018 | 831 | 0.110 |
Why?
|
| Adolescent | 5 | 2024 | 10078 | 0.110 |
Why?
|
| Alleles | 3 | 2021 | 1160 | 0.110 |
Why?
|
| Receptors, Interleukin | 1 | 2014 | 38 | 0.110 |
Why?
|
| Inflammation Mediators | 2 | 2018 | 164 | 0.100 |
Why?
|
| RNA, Ribosomal, 16S | 3 | 2022 | 269 | 0.100 |
Why?
|
| GATA5 Transcription Factor | 1 | 2014 | 7 | 0.100 |
Why?
|
| Antigen-Antibody Complex | 1 | 2014 | 89 | 0.100 |
Why?
|
| Bronchoconstriction | 1 | 2014 | 49 | 0.100 |
Why?
|
| Specific Pathogen-Free Organisms | 2 | 2009 | 85 | 0.100 |
Why?
|
| Dermatitis, Atopic | 1 | 2015 | 71 | 0.100 |
Why?
|
| Cell Proliferation | 4 | 2016 | 1790 | 0.100 |
Why?
|
| Proportional Hazards Models | 3 | 2023 | 920 | 0.100 |
Why?
|
| Interferon-gamma | 3 | 2018 | 479 | 0.100 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2014 | 130 | 0.100 |
Why?
|
| Intestinal Mucosa | 3 | 2015 | 834 | 0.100 |
Why?
|
| DNA | 2 | 2022 | 1274 | 0.100 |
Why?
|
| Adrenomedullin | 1 | 2013 | 6 | 0.100 |
Why?
|
| Cell Survival | 2 | 2011 | 1014 | 0.100 |
Why?
|
| Graft Rejection | 3 | 2013 | 1186 | 0.100 |
Why?
|
| Mites | 1 | 2013 | 17 | 0.100 |
Why?
|
| Chronic Disease | 2 | 2025 | 985 | 0.090 |
Why?
|
| Immunoglobulin G | 2 | 2013 | 480 | 0.090 |
Why?
|
| Sarcoidosis | 1 | 2013 | 93 | 0.090 |
Why?
|
| Fluorescent Dyes | 1 | 2013 | 257 | 0.090 |
Why?
|
| Sarcoidosis, Pulmonary | 1 | 2012 | 22 | 0.090 |
Why?
|
| Intercellular Junctions | 2 | 2002 | 69 | 0.090 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2012 | 35 | 0.090 |
Why?
|
| Homozygote | 2 | 2018 | 212 | 0.090 |
Why?
|
| Acute Disease | 3 | 2017 | 857 | 0.090 |
Why?
|
| Ligands | 3 | 2000 | 487 | 0.090 |
Why?
|
| United States | 5 | 2025 | 8184 | 0.090 |
Why?
|
| Quantitative Trait Loci | 3 | 2025 | 663 | 0.090 |
Why?
|
| Down-Regulation | 2 | 2011 | 529 | 0.090 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2013 | 189 | 0.080 |
Why?
|
| Phospholipases A | 2 | 2002 | 46 | 0.080 |
Why?
|
| Immunological Synapses | 1 | 2011 | 6 | 0.080 |
Why?
|
| Autopsy | 2 | 2021 | 131 | 0.080 |
Why?
|
| Molecular Sequence Data | 7 | 2007 | 2893 | 0.080 |
Why?
|
| Cytoprotection | 1 | 2011 | 51 | 0.080 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2011 | 59 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 700 | 0.080 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2010 | 37 | 0.080 |
Why?
|
| Mice, Inbred C3H | 2 | 2009 | 370 | 0.080 |
Why?
|
| Methacholine Chloride | 3 | 2024 | 61 | 0.080 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 2037 | 0.080 |
Why?
|
| Influenza A virus | 1 | 2011 | 177 | 0.080 |
Why?
|
| Case-Control Studies | 3 | 2024 | 1995 | 0.080 |
Why?
|
| Transplantation, Homologous | 2 | 2023 | 1026 | 0.080 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2009 | 14 | 0.080 |
Why?
|
| Genetic Variation | 1 | 2016 | 1445 | 0.070 |
Why?
|
| Lysophospholipids | 1 | 2009 | 67 | 0.070 |
Why?
|
| Transcription Factors | 2 | 2014 | 1717 | 0.070 |
Why?
|
| Histocytochemistry | 1 | 2009 | 122 | 0.070 |
Why?
|
| Reperfusion Injury | 1 | 2010 | 148 | 0.070 |
Why?
|
| Amino Acid Sequence | 4 | 2007 | 2002 | 0.070 |
Why?
|
| Protein Binding | 3 | 2022 | 1555 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 2666 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2007 | 403 | 0.070 |
Why?
|
| Antigens | 3 | 2013 | 225 | 0.070 |
Why?
|
| Young Adult | 5 | 2024 | 7504 | 0.070 |
Why?
|
| Societies, Medical | 2 | 2025 | 682 | 0.070 |
Why?
|
| Mice, Mutant Strains | 4 | 2008 | 217 | 0.070 |
Why?
|
| Cohort Studies | 3 | 2020 | 3202 | 0.070 |
Why?
|
| Smad Proteins | 1 | 2008 | 42 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2013 | 604 | 0.070 |
Why?
|
| ROC Curve | 2 | 2026 | 793 | 0.070 |
Why?
|
| Lymphoma, B-Cell | 1 | 1989 | 110 | 0.070 |
Why?
|
| Promyelocytic Leukemia Zinc Finger Protein | 2 | 2019 | 18 | 0.070 |
Why?
|
| Pyroglyphidae | 2 | 2020 | 15 | 0.070 |
Why?
|
| GTP-Binding Proteins | 1 | 2008 | 150 | 0.060 |
Why?
|
| GTPase-Activating Proteins | 1 | 2008 | 71 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2007 | 238 | 0.060 |
Why?
|
| Transduction, Genetic | 1 | 2007 | 161 | 0.060 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2007 | 107 | 0.060 |
Why?
|
| Conserved Sequence | 1 | 2007 | 209 | 0.060 |
Why?
|
| Airway Obstruction | 1 | 2008 | 112 | 0.060 |
Why?
|
| Myeloid Cells | 2 | 2019 | 121 | 0.060 |
Why?
|
| Genotype | 3 | 2018 | 1888 | 0.060 |
Why?
|
| Binding Sites | 2 | 2008 | 1158 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2010 | 668 | 0.060 |
Why?
|
| In Vitro Techniques | 3 | 2021 | 945 | 0.060 |
Why?
|
| Environment | 1 | 2008 | 233 | 0.060 |
Why?
|
| Genes, RAG-1 | 1 | 2005 | 11 | 0.060 |
Why?
|
| Homeodomain Proteins | 1 | 2009 | 566 | 0.060 |
Why?
|
| Receptors, IgE | 2 | 1996 | 6 | 0.060 |
Why?
|
| 5' Untranslated Regions | 1 | 2005 | 52 | 0.060 |
Why?
|
| Streptococcus pneumoniae | 1 | 2005 | 50 | 0.060 |
Why?
|
| Membrane Glycoproteins | 2 | 1998 | 446 | 0.060 |
Why?
|
| Gene Regulatory Networks | 1 | 2008 | 337 | 0.050 |
Why?
|
| Ovariectomy | 1 | 2025 | 94 | 0.050 |
Why?
|
| Interleukin-1beta | 1 | 2025 | 92 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2007 | 1145 | 0.050 |
Why?
|
| Mexico | 1 | 2024 | 75 | 0.050 |
Why?
|
| Inflammasomes | 1 | 2025 | 38 | 0.050 |
Why?
|
| Tertiary Lymphoid Structures | 1 | 2024 | 1 | 0.050 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2003 | 99 | 0.050 |
Why?
|
| Melanocytes | 1 | 2024 | 62 | 0.050 |
Why?
|
| Primary Cell Culture | 1 | 2024 | 84 | 0.050 |
Why?
|
| Interferons | 1 | 2025 | 114 | 0.050 |
Why?
|
| Bronchoalveolar Lavage | 2 | 2021 | 27 | 0.050 |
Why?
|
| Bone Marrow Transplantation | 2 | 2015 | 286 | 0.050 |
Why?
|
| Age of Onset | 1 | 2025 | 367 | 0.050 |
Why?
|
| Epitopes | 2 | 2022 | 259 | 0.050 |
Why?
|
| Androgens | 1 | 2024 | 164 | 0.050 |
Why?
|
| Lymphotoxin-alpha | 1 | 2003 | 41 | 0.050 |
Why?
|
| Mice, Inbred DBA | 5 | 1997 | 146 | 0.050 |
Why?
|
| Occludin | 2 | 2015 | 66 | 0.050 |
Why?
|
| Lipid Metabolism | 1 | 2025 | 221 | 0.050 |
Why?
|
| Cross-Priming | 1 | 2023 | 59 | 0.050 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2003 | 69 | 0.050 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2013 | 174 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 2783 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 3 | 2014 | 1028 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2023 | 4798 | 0.050 |
Why?
|
| Models, Immunological | 3 | 2002 | 86 | 0.050 |
Why?
|
| Viral Envelope Proteins | 2 | 1994 | 80 | 0.050 |
Why?
|
| Bacterial Infections | 1 | 2004 | 183 | 0.050 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2022 | 35 | 0.050 |
Why?
|
| Simplexvirus | 2 | 1994 | 66 | 0.050 |
Why?
|
| Personnel Selection | 1 | 2023 | 66 | 0.050 |
Why?
|
| Extracellular Matrix | 1 | 2024 | 258 | 0.050 |
Why?
|
| Antigens, Surface | 2 | 2015 | 100 | 0.050 |
Why?
|
| Cricetinae | 3 | 2008 | 533 | 0.050 |
Why?
|
| Angiotensin II | 1 | 2022 | 96 | 0.050 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2022 | 65 | 0.050 |
Why?
|
| HIV Infections | 1 | 2012 | 1018 | 0.050 |
Why?
|
| Goblet Cells | 2 | 2014 | 20 | 0.050 |
Why?
|
| Japan | 1 | 2022 | 303 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 2 | 2013 | 256 | 0.040 |
Why?
|
| DNA-Binding Proteins | 2 | 2013 | 1254 | 0.040 |
Why?
|
| Thorax | 1 | 2022 | 77 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 1565 | 0.040 |
Why?
|
| Telomere | 1 | 2023 | 130 | 0.040 |
Why?
|
| Octamer Transcription Factor-1 | 1 | 2021 | 20 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2026 | 1567 | 0.040 |
Why?
|
| Strongyloidiasis | 1 | 2021 | 6 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-maf | 1 | 2001 | 4 | 0.040 |
Why?
|
| Leukocyte Reduction Procedures | 1 | 2021 | 3 | 0.040 |
Why?
|
| Diphtheria Toxin | 1 | 2021 | 22 | 0.040 |
Why?
|
| Skin | 1 | 2024 | 591 | 0.040 |
Why?
|
| Leadership | 1 | 2023 | 159 | 0.040 |
Why?
|
| Faculty, Medical | 1 | 2023 | 193 | 0.040 |
Why?
|
| Rabies Vaccines | 1 | 2021 | 7 | 0.040 |
Why?
|
| Sex Factors | 1 | 2024 | 1137 | 0.040 |
Why?
|
| CD40 Ligand | 1 | 2001 | 79 | 0.040 |
Why?
|
| Dexamethasone | 1 | 2003 | 318 | 0.040 |
Why?
|
| Measles-Mumps-Rubella Vaccine | 1 | 2021 | 9 | 0.040 |
Why?
|
| Macromolecular Substances | 2 | 1998 | 162 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2023 | 358 | 0.040 |
Why?
|
| Weight Loss | 1 | 2022 | 245 | 0.040 |
Why?
|
| Mitochondria | 1 | 2025 | 647 | 0.040 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2021 | 85 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 2021 | 306 | 0.040 |
Why?
|
| Particulate Matter | 1 | 2022 | 138 | 0.040 |
Why?
|
| CD8 Antigens | 2 | 1992 | 82 | 0.040 |
Why?
|
| CD4 Antigens | 2 | 1992 | 81 | 0.040 |
Why?
|
| Germinal Center | 1 | 2021 | 66 | 0.040 |
Why?
|
| Vaccines, Subunit | 1 | 2020 | 54 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2020 | 25 | 0.040 |
Why?
|
| Mice, Inbred NOD | 2 | 2013 | 227 | 0.040 |
Why?
|
| CD11 Antigens | 1 | 2000 | 14 | 0.040 |
Why?
|
| Leukotriene C4 | 1 | 2000 | 21 | 0.040 |
Why?
|
| Protein Stability | 1 | 2020 | 105 | 0.040 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2000 | 38 | 0.040 |
Why?
|
| CD18 Antigens | 1 | 2000 | 22 | 0.040 |
Why?
|
| Chitinase-3-Like Protein 1 | 1 | 2020 | 9 | 0.040 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2020 | 11 | 0.040 |
Why?
|
| Fibrosis | 1 | 2021 | 234 | 0.040 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 1 | 2020 | 7 | 0.040 |
Why?
|
| CA-125 Antigen | 1 | 2020 | 24 | 0.040 |
Why?
|
| Blotting, Western | 3 | 2013 | 779 | 0.040 |
Why?
|
| Chemokine CXCL13 | 1 | 2020 | 19 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2001 | 426 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2000 | 77 | 0.040 |
Why?
|
| Mammals | 1 | 2022 | 268 | 0.040 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2020 | 58 | 0.040 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2020 | 98 | 0.040 |
Why?
|
| Organoids | 1 | 2021 | 91 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2022 | 2008 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2019 | 38 | 0.040 |
Why?
|
| V(D)J Recombination | 1 | 2019 | 13 | 0.040 |
Why?
|
| Fever | 1 | 2020 | 121 | 0.040 |
Why?
|
| Seasons | 1 | 2021 | 251 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2023 | 766 | 0.040 |
Why?
|
| Vital Capacity | 1 | 2020 | 74 | 0.040 |
Why?
|
| Cellular Reprogramming | 1 | 2019 | 51 | 0.040 |
Why?
|
| Trachea | 1 | 2000 | 246 | 0.040 |
Why?
|
| Clone Cells | 2 | 1997 | 220 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2020 | 353 | 0.040 |
Why?
|
| Connective Tissue Diseases | 1 | 2020 | 76 | 0.040 |
Why?
|
| Antigens, CD1d | 1 | 2019 | 32 | 0.040 |
Why?
|
| Cell Separation | 1 | 2019 | 200 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2005 | 2892 | 0.040 |
Why?
|
| Spleen | 4 | 2010 | 375 | 0.040 |
Why?
|
| Leukocyte Common Antigens | 1 | 1998 | 50 | 0.040 |
Why?
|
| Zebrafish | 1 | 2021 | 353 | 0.040 |
Why?
|
| Comorbidity | 1 | 2022 | 1032 | 0.040 |
Why?
|
| Homeostasis | 1 | 2021 | 474 | 0.040 |
Why?
|
| Congresses as Topic | 1 | 2019 | 123 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2000 | 419 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2001 | 447 | 0.040 |
Why?
|
| Motion | 1 | 1998 | 96 | 0.030 |
Why?
|
| Protein Folding | 1 | 2020 | 291 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2022 | 909 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 2 | 2013 | 356 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1999 | 304 | 0.030 |
Why?
|
| Chromatin | 1 | 2021 | 454 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 1999 | 312 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 1999 | 297 | 0.030 |
Why?
|
| Interleukin-12 | 1 | 2018 | 110 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2021 | 1527 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2018 | 301 | 0.030 |
Why?
|
| Actins | 2 | 2013 | 480 | 0.030 |
Why?
|
| Glycoproteins | 2 | 2003 | 221 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2026 | 1103 | 0.030 |
Why?
|
| Immunoglobulin Variable Region | 1 | 1997 | 87 | 0.030 |
Why?
|
| Heterozygote | 1 | 2018 | 390 | 0.030 |
Why?
|
| Minor Lymphocyte Stimulatory Antigens | 2 | 1996 | 3 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2021 | 1815 | 0.030 |
Why?
|
| Arthritis | 2 | 1994 | 49 | 0.030 |
Why?
|
| bcl-X Protein | 1 | 1996 | 57 | 0.030 |
Why?
|
| B7-2 Antigen | 1 | 1996 | 42 | 0.030 |
Why?
|
| Europe | 1 | 2017 | 356 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 1999 | 667 | 0.030 |
Why?
|
| Mice, Inbred Strains | 4 | 2000 | 281 | 0.030 |
Why?
|
| Rural Population | 1 | 2017 | 191 | 0.030 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2015 | 5 | 0.030 |
Why?
|
| Helminths | 1 | 2015 | 7 | 0.030 |
Why?
|
| Papain | 1 | 2015 | 7 | 0.030 |
Why?
|
| Helminthiasis | 1 | 2015 | 5 | 0.030 |
Why?
|
| Survival Rate | 1 | 2020 | 2040 | 0.030 |
Why?
|
| Liver Diseases, Parasitic | 1 | 1995 | 1 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2017 | 286 | 0.030 |
Why?
|
| Schistosomiasis mansoni | 1 | 1995 | 9 | 0.030 |
Why?
|
| Receptors, Calcitriol | 1 | 2016 | 130 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2015 | 138 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2016 | 164 | 0.030 |
Why?
|
| Mutation | 1 | 2007 | 4396 | 0.030 |
Why?
|
| Cell Division | 1 | 1996 | 689 | 0.030 |
Why?
|
| RNA, Bacterial | 1 | 2015 | 102 | 0.030 |
Why?
|
| Integrin alpha Chains | 1 | 2015 | 21 | 0.030 |
Why?
|
| Collagen | 2 | 1994 | 313 | 0.030 |
Why?
|
| Granuloma | 1 | 1995 | 65 | 0.030 |
Why?
|
| HLA-D Antigens | 1 | 1995 | 20 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 7386 | 0.030 |
Why?
|
| Lymphokines | 1 | 1995 | 74 | 0.030 |
Why?
|
| Permeability | 1 | 2015 | 145 | 0.030 |
Why?
|
| Transplantation Chimera | 1 | 2015 | 84 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 707 | 0.030 |
Why?
|
| Heart Transplantation | 1 | 2001 | 873 | 0.030 |
Why?
|
| Recombinant Proteins | 3 | 2002 | 993 | 0.030 |
Why?
|
| Major Histocompatibility Complex | 1 | 1995 | 89 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2014 | 175 | 0.030 |
Why?
|
| Metaplasia | 1 | 2014 | 40 | 0.030 |
Why?
|
| Virulence | 1 | 2015 | 280 | 0.030 |
Why?
|
| Microtubule-Organizing Center | 1 | 2013 | 5 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 1995 | 374 | 0.030 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2013 | 83 | 0.030 |
Why?
|
| Mice, Inbred CBA | 2 | 1995 | 51 | 0.030 |
Why?
|
| Heat-Shock Proteins | 1 | 1995 | 178 | 0.030 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 1994 | 106 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1995 | 213 | 0.020 |
Why?
|
| Receptor Activity-Modifying Protein 2 | 1 | 2013 | 2 | 0.020 |
Why?
|
| Calcitonin Receptor-Like Protein | 1 | 2013 | 3 | 0.020 |
Why?
|
| Thy-1 Antigens | 2 | 1994 | 17 | 0.020 |
Why?
|
| Iloprost | 1 | 2013 | 14 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2014 | 139 | 0.020 |
Why?
|
| Glucose-6-Phosphate Isomerase | 1 | 2013 | 8 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 2013 | 93 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2014 | 135 | 0.020 |
Why?
|
| Chicago | 1 | 2018 | 1513 | 0.020 |
Why?
|
| Cricetulus | 2 | 2008 | 123 | 0.020 |
Why?
|
| Transfection | 2 | 2008 | 883 | 0.020 |
Why?
|
| Genes, MHC Class I | 1 | 1992 | 47 | 0.020 |
Why?
|
| CHO Cells | 2 | 2008 | 188 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2015 | 249 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2013 | 119 | 0.020 |
Why?
|
| Maternal Exposure | 1 | 2013 | 68 | 0.020 |
Why?
|
| Demography | 1 | 2013 | 193 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2013 | 277 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1108 | 0.020 |
Why?
|
| Vaccines, DNA | 1 | 2012 | 20 | 0.020 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2012 | 70 | 0.020 |
Why?
|
| Autoantigens | 1 | 2013 | 145 | 0.020 |
Why?
|
| Prognosis | 1 | 2020 | 4112 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2012 | 218 | 0.020 |
Why?
|
| Group V Phospholipases A2 | 2 | 2002 | 11 | 0.020 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 1991 | 18 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 310 | 0.020 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2012 | 150 | 0.020 |
Why?
|
| Bacteria | 1 | 2015 | 545 | 0.020 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2014 | 332 | 0.020 |
Why?
|
| Species Specificity | 1 | 1992 | 690 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2012 | 264 | 0.020 |
Why?
|
| HIV-1 | 1 | 2012 | 179 | 0.020 |
Why?
|
| T-Box Domain Proteins | 1 | 2012 | 139 | 0.020 |
Why?
|
| Haplotypes | 1 | 1992 | 657 | 0.020 |
Why?
|
| Liver | 1 | 1995 | 1229 | 0.020 |
Why?
|
| Cell Count | 1 | 2010 | 195 | 0.020 |
Why?
|
| Base Sequence | 4 | 1995 | 2222 | 0.020 |
Why?
|
| Radiography | 1 | 2012 | 762 | 0.020 |
Why?
|
| Egg Proteins | 1 | 2009 | 10 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2014 | 618 | 0.020 |
Why?
|
| Antigens, Protozoan | 1 | 2009 | 22 | 0.020 |
Why?
|
| Dinoprostone | 1 | 2009 | 80 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2008 | 1946 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2010 | 153 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2009 | 102 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2010 | 186 | 0.020 |
Why?
|
| Antigens, Ly | 1 | 1989 | 37 | 0.020 |
Why?
|
| Transplantation Tolerance | 1 | 2010 | 145 | 0.020 |
Why?
|
| Plethysmography | 1 | 2008 | 16 | 0.020 |
Why?
|
| Smad3 Protein | 1 | 2008 | 25 | 0.020 |
Why?
|
| Smad4 Protein | 1 | 2008 | 26 | 0.020 |
Why?
|
| Bronchial Provocation Tests | 1 | 2008 | 24 | 0.020 |
Why?
|
| Smad2 Protein | 1 | 2008 | 25 | 0.020 |
Why?
|
| Blood Cell Count | 1 | 2008 | 68 | 0.020 |
Why?
|
| Aerosols | 1 | 2008 | 44 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2008 | 139 | 0.020 |
Why?
|
| Cell Line | 3 | 1999 | 2482 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2008 | 195 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2008 | 380 | 0.020 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2010 | 332 | 0.020 |
Why?
|
| Risk Factors | 1 | 2017 | 6224 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 731 | 0.010 |
Why?
|
| Pedigree | 1 | 2008 | 980 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2008 | 615 | 0.010 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2003 | 10 | 0.010 |
Why?
|
| H-2 Antigens | 2 | 1996 | 58 | 0.010 |
Why?
|
| Calcium | 1 | 2008 | 1196 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2003 | 278 | 0.010 |
Why?
|
| Respiratory Mechanics | 1 | 2003 | 109 | 0.010 |
Why?
|
| Neurofibromin 2 | 1 | 2002 | 31 | 0.010 |
Why?
|
| Aging | 1 | 2008 | 770 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2002 | 290 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2003 | 478 | 0.010 |
Why?
|
| TNF Receptor-Associated Factor 4 | 1 | 2000 | 1 | 0.010 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2000 | 6 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 1998 | 2063 | 0.010 |
Why?
|
| Larynx | 1 | 2000 | 36 | 0.010 |
Why?
|
| Phospholipases A2 | 1 | 2000 | 45 | 0.010 |
Why?
|
| Hybridomas | 1 | 2000 | 61 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2000 | 72 | 0.010 |
Why?
|
| Respiration Disorders | 1 | 2000 | 42 | 0.010 |
Why?
|
| Cross Reactions | 1 | 2000 | 116 | 0.010 |
Why?
|
| Muridae | 1 | 1999 | 9 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 1999 | 165 | 0.010 |
Why?
|
| Gene Library | 1 | 1999 | 126 | 0.010 |
Why?
|
| Lymphoma, T-Cell | 1 | 1999 | 60 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2002 | 571 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2000 | 303 | 0.010 |
Why?
|
| Incidence | 1 | 2003 | 1776 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1999 | 582 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1999 | 352 | 0.010 |
Why?
|
| Bronchoconstrictor Agents | 1 | 1998 | 12 | 0.010 |
Why?
|
| Antibodies, Helminth | 1 | 1998 | 12 | 0.010 |
Why?
|
| Airway Resistance | 1 | 1998 | 68 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 1998 | 102 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 1944 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1998 | 889 | 0.010 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1996 | 38 | 0.010 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1995 | 11 | 0.010 |
Why?
|
| beta 2-Microglobulin | 1 | 1995 | 23 | 0.010 |
Why?
|
| Schistosomiasis | 1 | 1994 | 5 | 0.010 |
Why?
|
| Synovial Membrane | 1 | 1993 | 33 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1993 | 273 | 0.010 |
Why?
|
| Listeriosis | 1 | 1994 | 91 | 0.010 |
Why?
|
| Cyclosporine | 1 | 1994 | 241 | 0.010 |
Why?
|
| Epithelium | 1 | 1993 | 316 | 0.010 |
Why?
|
| Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 1991 | 13 | 0.010 |
Why?
|
| Herpes Simplex | 1 | 1992 | 79 | 0.010 |
Why?
|
| Intestines | 1 | 1993 | 441 | 0.010 |
Why?
|
| Mice, Nude | 1 | 1991 | 830 | 0.000 |
Why?
|